Literature DB >> 24030926

Vitronectin--master controller or micromanager?

David I Leavesley1, Abhishek S Kashyap, Tristan Croll, Manaswini Sivaramakrishnan, Ali Shokoohmand, Brett G Hollier, Zee Upton.   

Abstract

The concept that the mammalian glycoprotein vitronectin acts as a biological 'glue' and key controller of mammalian tissue repair and remodelling activity is emerging from nearly 50 years of experimental in vitro and in vivo data. Unexpectedly, the vitronectin-knockout (VN-KO) mouse was found to be viable and to have largely normal phenotype. However, diligent observation revealed that the VN-KO animal exhibits delayed coagulation and poor wound healing. This is interpreted to indicate that VN occupies a role in the earliest events of thrombogenesis and tissue repair. VN is the foundation upon which the thrombus grows in an organised structure. In addition to sealing the wound, the thrombus also serves to protect the underlying tissue from oxidation, is a reservoir of mitogens and tissue repair mediators, and provides a provisional scaffold for the repairing tissue. In the absence of VN (e.g., VN-KO animal), this cascade is disrupted before it begins. A wide variety of biologically active species associate with VN. Although initial studies were focused on mitogens, other classes of bioactives (e.g., glycosaminoglycans and metalloproteinases) are now also known to specifically interact with VN. Although some interactions are transient, others are long-lived and often result in multi-protein complexes. Multi-protein complexes provide several advantages: prolonging molecular interactions, sustaining local concentrations, facilitating co-stimulation of cell surface receptors and thereby enhancing cellular/biological responses. We contend that these, or equivalent, multi-protein complexes facilitate VN polyfunctionality in vivo. It is also likely that many of the species demonstrated to associate with VN in vitro, also associate with VN in vivo in similar multi-protein complexes. Thus, the predominant biological function of VN is that of a master controller of the extracellular environment; informing, and possibly instructing cells 'where' to behave, 'when' to behave and 'how' to behave (i.e., appropriately for the current circumstance).
© 2013 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  coagulation; extracellular matrix; growth factor; multi-protein complex; thrombogenesis; vitronectin

Mesh:

Substances:

Year:  2013        PMID: 24030926     DOI: 10.1002/iub.1203

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  38 in total

1.  Vitronectin from brain pericytes promotes adult forebrain neurogenesis by stimulating CNTF.

Authors:  Cuihong Jia; Matthew P Keasey; Hannah M Malone; Chiharu Lovins; Richard R Sante; Vlad Razskazovskiy; Theo Hagg
Journal:  Exp Neurol       Date:  2018-11-06       Impact factor: 5.330

2.  D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR.

Authors:  Gabriele Eden; Marco Archinti; Ralitsa Arnaudova; Giuseppina Andreotti; Andrea Motta; Federico Furlan; Valentina Citro; Maria Vittoria Cubellis; Bernard Degryse
Journal:  Cell Mol Life Sci       Date:  2017-11-28       Impact factor: 9.261

3.  The iron-regulated surface determinant B (IsdB) protein from Staphylococcus aureus acts as a receptor for the host protein vitronectin.

Authors:  Giampiero Pietrocola; Angelica Pellegrini; Mariangela J Alfeo; Loredana Marchese; Timothy J Foster; Pietro Speziale
Journal:  J Biol Chem       Date:  2020-06-04       Impact factor: 5.157

4.  Vitronectin: a promising breast cancer serum biomarker for early diagnosis of breast cancer in patients.

Authors:  Wende Hao; Xuhui Zhang; Bingshui Xiu; Xiqin Yang; Shuofeng Hu; Zhiqiang Liu; Cuimi Duan; Shujuan Jin; Xiaomin Ying; Yanfeng Zhao; Xiaowei Han; Xiaopeng Hao; Yawen Fan; Heather Johnson; Di Meng; Jenny L Persson; Heqiu Zhang; XiaoYan Feng; Yan Huang
Journal:  Tumour Biol       Date:  2016-01-11

5.  Proteomic analysis of calcium-enriched sol-gel biomaterials.

Authors:  F Romero-Gavilán; Nuno Araújo-Gomes; A Cerqueira; I García-Arnáez; C Martínez-Ramos; M Azkargorta; I Iloro; F Elortza; M Gurruchaga; J Suay; I Goñi
Journal:  J Biol Inorg Chem       Date:  2019-04-27       Impact factor: 3.358

6.  Blood vitronectin is a major activator of LIF and IL-6 in the brain through integrin-FAK and uPAR signaling.

Authors:  Matthew P Keasey; Cuihong Jia; Lylyan F Pimentel; Richard R Sante; Chiharu Lovins; Theo Hagg
Journal:  J Cell Sci       Date:  2018-02-02       Impact factor: 5.285

7.  Proteomic Architecture of Human Coronary and Aortic Atherosclerosis.

Authors:  David M Herrington; Chunhong Mao; Sarah J Parker; Zongming Fu; Guoqiang Yu; Lulu Chen; Vidya Venkatraman; Yi Fu; Yizhi Wang; Timothy D Howard; Goo Jun; Caroline F Zhao; Yongmei Liu; Georgia Saylor; Weston R Spivia; Grace B Athas; Dana Troxclair; James E Hixson; Richard S Vander Heide; Yue Wang; Jennifer E Van Eyk
Journal:  Circulation       Date:  2018-06-19       Impact factor: 29.690

Review 8.  Extracellular matrix assembly: a multiscale deconstruction.

Authors:  Janna K Mouw; Guanqing Ou; Valerie M Weaver
Journal:  Nat Rev Mol Cell Biol       Date:  2014-11-05       Impact factor: 94.444

9.  Sialylation of vitronectin regulates stress fiber formation and cell spreading of dermal fibroblasts via a heparin-binding site.

Authors:  Yasunori Miyamoto; Mio Tanabe; Kimie Date; Kanoko Sakuda; Kotone Sano; Haruko Ogawa
Journal:  Glycoconj J       Date:  2016-03-15       Impact factor: 2.916

10.  Calcium and hydroxyapatite binding site of human vitronectin provides insights to abnormal deposit formation.

Authors:  Kyungsoo Shin; James E Kent; Chandan Singh; Lynn M Fujimoto; Jinghua Yu; Ye Tian; Wonpil Im; Francesca M Marassi
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.